Drug Prices

Health and Human Services Secretary Alex Azar today provided additional information on steps the agency will take to implement the president’s blueprint to lower prescription drug costs.
Another week, another drug industry-funded consultant attempting to divert attention away from the high and rising costs of prescription drugs by attacking the 340B drug pricing program.
President Trump today unveiled his administration’s blueprint to lower prescription drug prices, which also solicits input on potential actions the Department of Health and Human Services may take to improve competition and negotiation and lower costs.
Contact:  Marie Johnson, (202) 626-2351                Colin Milligan, (202) 638-5491
The Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies today held a hearing on the Department of Health and Human Services’ funding request for fiscal year 2019.
Reducing regulations and expanding care models that ensure coordination and reward performance are two ways to address health care prices, AHA General Counsel Melinda Hatton said today during a Kaiser Family Foundation panel discussion focused on the issue.
Rep. Peter Roskam (R-IL), chairman of the Health Subcommittee on Ways and Means, today stressed the need for Congress to reduce certain regulations on providers that “have no relationship to patient health.”
Watch the video Centers for Medicare & Medicaid Services Administrator Seema Verma today discussed a number of efforts underway at the agency, including many to reduce regulatory burdens on providers.   
Watch the video The timing of the AHA Annual Membership Meeting presents a “real opportunity to talk with your members of Congress about what you are doing back home,” specifically how hospitals are improving value and affordability, coping with escalating drug prices and working at the front…
AHA President and CEO Rick Pollack and AARP CEO Jo Ann Jenkins today authored an OpEd in The Hill discussing the skyrocketing costs of prescription drugs and what they mean for patients and our health care system.